As CTRP3 has documented anti-inflammatory and cardioprotective properties, we hypothesized that its epicardial adipose tissue gene expression or circulating levels may differ in patients with T2DM and CAD, compared to patients without those conditions thus contributing to accelerated coronary atherosclerosis. Here, C1QTNF3 is linked to type 2 diabetes mellitus.